Medicinal Chemistry Journals Welcome New Associate Editors - ACS Axial | ACS Publications

Medicinal Chemistry Journals Welcome New Associate Editors

The Journal of Medicinal Chemistry (JMC) and ACS Medicinal Chemistry Letters (ACS MCL) are thrilled to welcome a new cohort of Associate Editors to their respective editorial teams. To welcome them, we asked each new Associate Editor why they’re excited to be a part of their journal’s team. Read below to get to know them!

New Journal of Medicinal Chemistry Associate Editors

James Barrow, Lieber Institute for Brain Development and Johns Hopkins University

“I am thrilled to join the JMC editorial board because it is the premier journal in the field, and I want to help even further raise its stature. Medicinal chemistry is driving exciting advances in medicine, not only by the new compounds prepared, but also new methodology to quickly prepare and evaluate high quality candidates.”

Kelly Chibale, University of Cape Town

“I am excited to join JMC as an Editor for two reasons. First, this gives me a platform to serve the community. Second, this provides me with an opportunity to contribute to sustaining what is excellent about JMC while also being an agent of change towards making JMC more than a place to publish but a place to learn about integrated drug discovery. In doing so it is my hope that authors will have the best possible experience regardless of the decision made on their manuscript’.”

Stefan Laufer, University of Tübingen

“I’m highly excited about my new appointment as medicinal chemistry brings chemical science to the patient, and JMC is at the cutting edge here!”

New ACS Medicinal Chemistry Letters Associate Editors

Jeff Aubé, UNC Chapel Hill

“I’ve always loved the ‘literary’ aspects of science, both as an element of our culture and as an essential step in the scientific method. I am deeply honored by this chance to serve our community.”

Maria Jesus Blanco, Sage Therapeutics

“I am passionate about medicinal chemistry and drug discovery, in particular CNS disorders. As an Associate Editor for ACS MCL, I want to increase the visibility of the field, highlighting innovation in medicinal chemistry towards clinical translation to help patients and their families.”

Want more stories like this delivered to your inbox?

Sign up for our newsletter to receive a selection of stories related to your favorite topics.

  • This field is for validation purposes and should be left unchanged.